Why #BVaccinated?

23 Feb

What is the cost of meningococcal disease?

Who does it impact?

When/for whom should vaccination be recommended?

These are some of the questions that policymakers will ask as they consider how to recommend the new vaccines to protect against serogroup B meningococcal disease.

To find the answers, we believe it is necessary to talk—and listen to—the people directly affected by the disease.

That starts with survivors, but also includes the families and friends of those who get sick; parents, students, faculty, staff and community members who have experienced a case, or an outbreak, on campus; and healthcare professionals who must make a difficult diagnosis and fight a fast-moving disease.

NMA has brought together a cross-section of advocates to give voice to the concerns of all of these groups in a new report: Beyond the Science: Putting a Face on Meningococcal Disease.
cover

As national policy is discussed and implemented, we urge all those involved to consider these perspectives, especially in light of recent cases and outbreaks on college campuses.

For the next few weeks we’ll be making the case that routinely vaccinating our children against this disease is the right thing to do, by taking an in-depth look at the stories and topics covered in this report.

We hope you will follow along, ask questions, share your thoughts and spread the word using #BVaccinated.

Advertisements

Share your thoughts

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: